MedPath

PULMOREX EXPECTORANT LIQ

PULMOREX EXPECTORANT LIQ

Discontinued
DIN Number

00766380

Drug Class

Human

Market Date

Dec 31, 1988

Company
HC

nutribon (1986) inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00766380
AIG Number0320327001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05CA10 COMBINATIONS
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification48:16.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

AMMONIUM CHLORIDEActive
Strength: 125 MG / 5 ML
Monograph: AMMONIUM CHLORIDE
DIPHENHYDRAMINE HYDROCHLORIDEActive
Strength: 12.5 MG / 5 ML
Monograph: DIPHENHYDRAMINE HYDROCHLORIDE
GUAIFENESINActive
Strength: 100 MG / 5 ML
Monograph: GUAIFENESIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.